Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   
Gene: IGHV3-72 (immunoglobulin heavy variable 3-72) Homo sapiens
Analyze
Symbol: IGHV3-72
Name: immunoglobulin heavy variable 3-72
Description: Predicted to have antigen binding activity and immunoglobulin receptor binding activity. Predicted to be involved in several processes, including activation of immune response; defense response to other organism; and phagocytosis. Predicted to localize to external side of plasma membrane and immunoglobulin complex, circulating; INTERACTS WITH carbon nanotube (ortholog); cyclophosphamide (ortholog).
Type: gene
RefSeq Status: VALIDATED
Also known as: IGHV372; VH
Orthologs:
Allele / Splice: See ClinVar data
Latest Assembly: GRCh38 - Human Genome Assembly GRCh38
NCBI Annotation Information: Annotation category: partial on reference assembly
Position:
Human AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
GRCh38 Ensembl14106,790,691 - 106,791,233 (-)EnsemblGRCh38hg38GRCh38
GRCh3814106,790,692 - 106,791,153 (-)NCBIGRCh38GRCh38hg38GRCh38
GRCh3714107,198,930 - 107,199,391 (-)NCBIGRCh37GRCh37hg19GRCh37
Build 3614106,269,975 - 106,270,436 (-)NCBINCBI36hg18NCBI36
Celera1487,151,952 - 87,152,413 (-)NCBI
Cytogenetic Map14q32.33NCBI
HuRef1487,351,770 - 87,364,760 (-)NCBIHuRef
CHM1_114107,127,648 - 107,128,109 (-)NCBICHM1_1
JBrowse: View Region in Genome Browser (JBrowse)
Model


Disease Annotations
Gene-Chemical Interaction Annotations
Gene Ontology Annotations
References - curated
References - uncurated

Genomics

Comparative Map Data
miRNA Target Status

Expression

RNA-SEQ Expression

Sequence

Nucleotide Sequences
Protein Sequences
Clinical Variants

Additional Information

External Database Links
 
More on IGHV3-72
Alliance Gene
NCBI Gene
Ensembl Gene
JBrowse: hg19 hg38
HGNC Report
NCBI Genome Data Viewer

RGD Object Information
RGD ID: 1349216
Created: 2005-03-08
Species: Homo sapiens
Last Modified: 2020-06-18
Status: ACTIVE



NHLBI Logo

RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.